- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2014
- Public Summary Document (PSD) July 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2014 PBAC Meeting - Word
Ranibizumab – July 2014
RANIBIZUMAB (DME), 2.3 mg/0.23 mL injection, 0.23 mL vial, Lucentis®, Novartis Pharmaceuticals Australia Pty Ltd
Last updated
8 November 2023